FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

2.

Additional Proof of the Different Cognitive Effects of ARSIs for Prostate Cancer.

3.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

4.

Minimally invasive prostate cancer treatment shows success in first patient

5.

NIH research cuts leave cancer patient facing hard choice


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot